Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

b.braun melsungen ag, nemecko - ibuprofén - 07 - analgetica, antipyretica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

haleon czech republic s.r.o., Česká republika - diklofenak - 29 - antirheumatica, antiphlogistica, antiuratica

Uni Eropa - Slovak - EMA (European Medicines Agency)

pfizer europe ma eeig - parekoxib sodný - bolesť, pooperačná - coxibs, antiinflammatory and antirheumatic products - na krátkodobé liečenie pooperačnej bolesti u dospelých.

Uni Eropa - Slovak - EMA (European Medicines Agency)

warner chilcott uk ltd. - testosterón - sexuálne dysfunkcie, psychologické - pohlavné hormóny a modulátory z genitálny systém, - intrinsa je indikovaný na liečbu hypoactive sexuálnou túžbou ochorenia (hsdd) u dvojstranne oophorectomised a po hysterektómii (chirurgicky vyvolaná menopauza) žien súbežné estrogén terapia.

Uni Eropa - Slovak - EMA (European Medicines Agency)

warner chilcott  deutschland gmbh - testosterón - sexuálne dysfunkcie, psychologické - pohlavné hormóny a modulátory z genitálny systém, - livensa je indikovaný na liečbu hypoactive sexuálnou túžbou ochorenia (hsdd) u dvojstranne oophorectomised a po hysterektómii (chirurgicky vyvolaná menopauza) žien súbežné estrogén terapia.

Uni Eropa - Slovak - EMA (European Medicines Agency)

pfizer europe ma eeig - tofacitinib - artritída, reumatoidná artritída - imunosupresíva - rheumatoid arthritistofacitinib in combination with methotrexate (mtx) is indicated for the treatment of moderate to severe active rheumatoid arthritis (ra) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (dmards) (see section 5. tofacitinib can be given as monotherapy in case of intolerance to mtx or when treatment with mtx is inappropriate (see sections 4. 4 a 4. psoriatic arthritistofacitinib in combination with mtx is indicated for the treatment of active psoriatic arthritis (psa) in adult patients who have had an inadequate response or who have been intolerant to a prior disease modifying antirheumatic drug (dmard) therapy (see section 5. ulcerative colitistofacitinib is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent (see section 5. tofacitinib is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (rheumatoid factor positive [rf+] or negative [rf-] polyarthritis and extended oligoarthritis), and juvenile psoriatic arthritis (psa) in patients 2 years of age and older, who have responded inadequately to previous therapy with disease modifying antirheumatic drugs (dmards). tofacitinib can be given in combination with methotrexate (mtx) or as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. ankylosing spondylitistofacitinib is indicated for the treatment of adult patients with active ankylosing spondylitis (as) who have responded inadequately to conventional therapy.

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

ucb s.r.o., Česká republika - hydroxyzín - 70 - anxiolytica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

bb pharma a.s., Česká republika - ergokalciferol - 86 - vitamina, vitagena

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - sulfadiazín, strieborná soľ - 46 - dermatologica

Slovakia - Slovak - ŠÚKL (Štátny ústav pre kontrolu liečiv)

sandoz pharmaceuticals d.d., slovinsko - diklofenak - 29 - antirheumatica, antiphlogistica, antiuratica